Digital Health News

Indus Health Plus launches MEDNAwise, a genetic solution in precision medicine

Indus Health Plus has launched MEDNAwise to expand its genetic testing portfolio. It is a genetic solution in precision medicine. MEDNAwise suggests to choose the right drug, manage the treatment and makes the drug effective. MEDNAwise can also be used as personalized medication guide.

   The MEDNAwise testing focuses on Pharmacogenomics. Pharmacogenomics is a study that uses genetic information to track response to certain drugs or medicines. This helps the doctors prescribe safer and more effective medication. Genes influence drug metabolism and sensitivity towards drug. There are two types of people- those who respond to the drug and those who don’t respond to the drug. Those who do not respond, requires an alternate medication or another dose.

     MEDNAwise is a saliva based genetic test and can be done at home. It is available at the cost of INR 9,999 including taxes. It is designed for all age groups and has 11 categories and 72 medicines linked with different health departments. The categories under MEDNAwise testing are anesthesiology, neurology, cardiology, oncology, psychiatry, gastroenterology, gynecology, organ transplantation, pulmonology and infectious disease. MEDNAwise report helps to understand the patient and let the doctor to make informed decisions to respective treatments.  


Leave a Reply

Your email address will not be published. Required fields are marked *